{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:56:12Z","timestamp":1792518972124,"version":"4.5.0"},"reference-count":152,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1038\/s41574-025-01190-0","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T14:03:10Z","timestamp":1760450590000},"page":"201-213","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The complexity of the relationship between thyroid disease and body weight"],"prefix":"10.1038","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2238-2666","authenticated-orcid":false,"given":"Jacqueline","family":"Jonklaas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,14]]},"reference":[{"key":"1190_CR1","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1001\/jama.2023.19897","volume":"330","author":"A Elmaleh-Sachs","year":"2023","unstructured":"Elmaleh-Sachs, A. et al. Obesity management in adults: a review. JAMA 330, 2000\u20132015 (2023).","journal-title":"JAMA"},{"key":"1190_CR2","doi-asserted-by":"publisher","first-page":"9434","DOI":"10.3390\/ijerph18189434","volume":"18","author":"K Walczak","year":"2021","unstructured":"Walczak, K. & Sieminska, L. Obesity and thyroid axis. Int. J. Env. Res. Public. Health 18, 9434 (2021).","journal-title":"Int. J. Env. Res. Public. Health"},{"key":"1190_CR3","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s40519-023-01593-w","volume":"28","author":"W Wu","year":"2023","unstructured":"Wu, W. et al. Endocrine, genetic, and microbiome nexus of obesity and potential role of postbiotics: a narrative review. Eat. Weight. Disord. 28, 84 (2023).","journal-title":"Eat. Weight. Disord."},{"key":"1190_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/MED.0b013e3282f43a5b","volume":"15","author":"A Lenz","year":"2008","unstructured":"Lenz, A. & Diamond, F. B. Jr. Obesity: the hormonal milieu. Curr. Opin. Endocrinol. Diabetes Obes. 15, 9\u201320 (2008).","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"1190_CR5","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.cell.2007.04.001","volume":"129","author":"AP Coll","year":"2007","unstructured":"Coll, A. P., Farooqi, I. S. & O\u2019Rahilly, S. The hormonal control of food intake. Cell 129, 251\u2013262 (2007).","journal-title":"Cell"},{"key":"1190_CR6","doi-asserted-by":"publisher","first-page":"204201882091786","DOI":"10.1177\/2042018820917869","volume":"11","author":"P Teixeira","year":"2020","unstructured":"Teixeira, P., Dos Santos, P. B. & Pazos-Moura, C. C. The role of thyroid hormone in metabolism and metabolic syndrome. Ther. Adv. Endocrinol. Metab. 11, 2042018820917869 (2020).","journal-title":"Ther. Adv. Endocrinol. Metab."},{"key":"1190_CR7","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1210\/clinem\/dgad072","volume":"108","author":"L Li","year":"2023","unstructured":"Li, L., Song, Y., Shi, Y. & Sun, L. Thyroid hormone receptor-\u03b2 agonists in NAFLD therapy: possibilities and challenges. J. Clin. Endocrinol. Metab. 108, 1602\u20131613 (2023).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1190_CR8","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1007\/s12020-023-03503-7","volume":"84","author":"H Alwan","year":"2024","unstructured":"Alwan, H. et al. A systematic review and meta-analysis investigating the relationship between metabolic syndrome and the incidence of thyroid diseases. Endocrine 84, 320\u2013327 (2024).","journal-title":"Endocrine"},{"key":"1190_CR9","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.eprac.2024.11.011","volume":"31","author":"OH Roa Due\u00f1as","year":"2025","unstructured":"Roa Due\u00f1as, O. H. et al. Thyroid function and anthropometric measures: a systematic review and meta-analysis. Endocr. Pract. 31, 198\u2013207 (2025).","journal-title":"Endocr. Pract."},{"key":"1190_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0034979","volume":"7","author":"CM Kitahara","year":"2012","unstructured":"Kitahara, C. M. et al. Body fatness and markers of thyroid function among U.S. men and women. PLoS ONE 7, e34979 (2012).","journal-title":"PLoS ONE"},{"key":"1190_CR11","doi-asserted-by":"publisher","first-page":"4019","DOI":"10.1210\/jc.2004-2225","volume":"90","author":"N Knudsen","year":"2005","unstructured":"Knudsen, N. et al. Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population. J. Clin. Endocrinol. Metab. 90, 4019\u20134024 (2005).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1190_CR12","doi-asserted-by":"publisher","first-page":"3562","DOI":"10.1210\/jc.2013-1315","volume":"98","author":"PN Taylor","year":"2013","unstructured":"Taylor, P. N., Razvi, S., Pearce, S. H. & Dayan, C. M. Clinical review: a review of the clinical consequences of variation in thyroid function within the reference range. J. Clin. Endocrinol. Metab. 98, 3562\u20133571 (2013).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1190_CR13","doi-asserted-by":"publisher","first-page":"1029376","DOI":"10.3389\/fendo.2022.1029376","volume":"13","author":"C Mele","year":"2022","unstructured":"Mele, C. et al. The pattern of TSH and fT4 levels across different BMI ranges in a large cohort of euthyroid patients with obesity. Front. Endocrinol. 13, 1029376 (2022).","journal-title":"Front. Endocrinol."},{"key":"1190_CR14","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1111\/j.1365-2362.2011.02526.x","volume":"41","author":"F Soriguer","year":"2011","unstructured":"Soriguer, F. et al. Thyroid hormone levels predict the change in body weight: a prospective study. Eur. J. Clin. Invest. 41, 1202\u20131209 (2011).","journal-title":"Eur. J. Clin. Invest."},{"key":"1190_CR15","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1093\/ajcn\/85.2.440","volume":"85","author":"E Ortega","year":"2007","unstructured":"Ortega, E., Pannacciulli, N., Bogardus, C. & Krakoff, J. Plasma concentrations of free triiodothyronine predict weight change in euthyroid persons. Am. J. Clin. Nutr. 85, 440\u2013445 (2007).","journal-title":"Am. J. Clin. Nutr."},{"key":"1190_CR16","doi-asserted-by":"publisher","first-page":"1333033","DOI":"10.3389\/fendo.2024.1333033","volume":"15","author":"Z Tian","year":"2024","unstructured":"Tian, Z. et al. Total weight loss induces the alteration in thyroid function after bariatric surgery. Front. Endocrinol. 15, 1333033 (2024).","journal-title":"Front. Endocrinol."},{"key":"1190_CR17","doi-asserted-by":"publisher","first-page":"4659","DOI":"10.1210\/jc.2005-0920","volume":"90","author":"P Kok","year":"2005","unstructured":"Kok, P. et al. High circulating thyrotropin levels in obese women are reduced after body weight loss induced by caloric restriction. J. Clin. Endocrinol. Metab. 90, 4659\u20134663 (2005).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1190_CR18","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1038\/ijo.2017.28","volume":"41","author":"G Liu","year":"2017","unstructured":"Liu, G. et al. Thyroid hormones and changes in body weight and metabolic parameters in response to weight loss diets: the POUNDS LOST trial. Int. J. Obes. 41, 878\u2013886 (2017).","journal-title":"Int. J. Obes."},{"key":"1190_CR19","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1089\/thy.2013.0055","volume":"24","author":"RV Agnihothri","year":"2014","unstructured":"Agnihothri, R. V. et al. Moderate weight loss is sufficient to affect thyroid hormone homeostasis and inhibit its peripheral conversion. Thyroid 24, 19\u201326 (2014).","journal-title":"Thyroid"},{"key":"1190_CR20","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/s41574-019-0176-8","volume":"15","author":"M Bluher","year":"2019","unstructured":"Bluher, M. Obesity: global epidemiology and pathogenesis. Nat. Rev. Endocrinol. 15, 288\u2013298 (2019).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1190_CR21","first-page":"51","volume":"8","author":"S Kalra","year":"2020","unstructured":"Kalra, S., Kapoor, N., Bhattacharya, S., Aydin, H. & Coetzee, A. Barocrinology: the endocrinology of obesity from bench to bedside. Med. Sci. 8, 51 (2020).","journal-title":"Med. Sci."},{"key":"1190_CR22","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1079\/PHN2002431","volume":"6","author":"K Ball","year":"2003","unstructured":"Ball, K., Crawford, D., Ireland, P. & Hodge, A. Patterns and demographic predictors of 5-year weight change in a multi-ethnic cohort of men and women in Australia. Public. Health Nutr. 6, 269\u2013281 (2003).","journal-title":"Public. Health Nutr."},{"key":"1190_CR23","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1097\/GME.0000000000001792","volume":"28","author":"MG Knight","year":"2021","unstructured":"Knight, M. G. et al. Weight regulation in menopause. Menopause 28, 960\u2013965 (2021).","journal-title":"Menopause"},{"key":"1190_CR24","doi-asserted-by":"publisher","first-page":"1400204","DOI":"10.3389\/fendo.2024.1400204","volume":"15","author":"HJ Gong","year":"2024","unstructured":"Gong, H. J., Tang, X. & Zhou, J. B. The association between weight change patterns and obesity-related complex multimorbidity: evidence from NHANES. Front. Endocrinol. 15, 1400204 (2024).","journal-title":"Front. Endocrinol."},{"key":"1190_CR25","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/s13679-024-00555-2","volume":"13","author":"MD Hurtado","year":"2024","unstructured":"Hurtado, M. D., Saadedine, M., Kapoor, E., Shufelt, C. L. & Faubion, S. S. Weight gain in midlife women. Curr. Obes. Rep. 13, 352\u2013363 (2024).","journal-title":"Curr. Obes. Rep."},{"key":"1190_CR26","doi-asserted-by":"publisher","first-page":"2312885","DOI":"10.1080\/09513590.2024.2312885","volume":"40","author":"S Palacios","year":"2024","unstructured":"Palacios, S., Chedraui, P., S\u00e1nchez-Borrego, R., Coronado, P. & Nappi, R. E. Obesity and menopause. Gynecol. Endocrinol. 40, 2312885 (2024).","journal-title":"Gynecol. Endocrinol."},{"key":"1190_CR27","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1073\/pnas.0610787104","volume":"104","author":"S Musatov","year":"2007","unstructured":"Musatov, S. et al. Silencing of estrogen receptor \u03b1 in the ventromedial nucleus of hypothalamus leads to metabolic syndrome. Proc. Natl Acad. Sci. USA 104, 2501\u20132506 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1190_CR28","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1089\/jwh.2008.1019","volume":"18","author":"PG Moorman","year":"2009","unstructured":"Moorman, P. G. et al. A prospective study of weight gain after premenopausal hysterectomy. J. Womens Health 18, 699\u2013708 (2009).","journal-title":"J. Womens Health"},{"key":"1190_CR29","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1080\/13697137.2024.2374760","volume":"27","author":"S Palacios","year":"2024","unstructured":"Palacios, S. et al. Management of obesity in menopause. Climacteric 27, 357\u2013363 (2024).","journal-title":"Climacteric"},{"key":"1190_CR30","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1089\/thy.2011.0054","volume":"21","author":"J Jonklaas","year":"2011","unstructured":"Jonklaas, J. & Nsouli-Maktabi, H. Weight changes in euthyroid patients undergoing thyroidectomy. Thyroid 21, 1343\u20131351 (2011).","journal-title":"Thyroid"},{"key":"1190_CR31","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/j.1365-2265.2011.04264.x","volume":"76","author":"HN Polotsky","year":"2012","unstructured":"Polotsky, H. N., Brokhin, M., Omry, G., Polotsky, A. J. & Tuttle, R. M. Iatrogenic hyperthyroidism does not promote weight loss or prevent ageing-related increases in body mass in thyroid cancer survivors. Clin. Endocrinol. 76, 582\u2013585 (2012).","journal-title":"Clin. Endocrinol."},{"key":"1190_CR32","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1089\/thy.2017.0216","volume":"28","author":"N Singh Ospina","year":"2018","unstructured":"Singh Ospina, N. et al. Weight changes after thyroid surgery for patients with benign thyroid nodules and thyroid cancer: population-based study and systematic review and meta-analysis. Thyroid 28, 639\u2013649 (2018).","journal-title":"Thyroid"},{"key":"1190_CR33","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1210\/clinem\/dgaa754","volume":"106","author":"CN Huynh","year":"2021","unstructured":"Huynh, C. N., Pearce, J. V., Kang, L. & Celi, F. S. Weight gain after thyroidectomy: a systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 106, 282\u2013291 (2021). A meta-analysis of 17 studies examining the weight gain of patients undergoing thyroidectomy, and showing the greatest weight gain in those patients undergoing thyroidectomy due to hyperthyroidism.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1190_CR34","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.eprac.2025.02.005","volume":"31","author":"A Dharia","year":"2025","unstructured":"Dharia, A., Desai, D. & Desai, K. Exploring the link between thyroid disorders and obesity: mechanisms, impacts, and clinical implications. Endocr. Pract. 31, 660\u2013667 (2025).","journal-title":"Endocr. Pract."},{"key":"1190_CR35","doi-asserted-by":"publisher","first-page":"R157","DOI":"10.1530\/JME-17-0319","volume":"60","author":"KA Iwen","year":"2018","unstructured":"Iwen, K. A., Oelkrug, R. & Brabant, G. Effects of thyroid hormones on thermogenesis and energy partitioning. J. Mol. Endocrinol. 60, R157\u2013R170 (2018).","journal-title":"J. Mol. Endocrinol."},{"key":"1190_CR36","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1210\/js.2018-00423","volume":"3","author":"S Yavuz","year":"2019","unstructured":"Yavuz, S., Salgado Nunez Del Prado, S. & Celi, F. S. Thyroid hormone action and energy expenditure. J. Endocr. Soc. 3, 1345\u20131356 (2019).","journal-title":"J. Endocr. Soc."},{"key":"1190_CR37","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1089\/thy.2019.0237","volume":"29","author":"A Basolo","year":"2019","unstructured":"Basolo, A. et al. Effects of short-term fasting and different overfeeding diets on thyroid hormones in healthy humans. Thyroid 29, 1209\u20131219 (2019).","journal-title":"Thyroid"},{"key":"1190_CR38","doi-asserted-by":"publisher","first-page":"572","DOI":"10.3390\/ph16040572","volume":"16","author":"G Petito","year":"2023","unstructured":"Petito, G. et al. Adipose tissue remodeling in obesity: an overview of the actions of thyroid hormones and their derivatives. Pharmaceuticals 16, 572 (2023).","journal-title":"Pharmaceuticals"},{"key":"1190_CR39","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1089\/thy.2007.0266","volume":"18","author":"B Kim","year":"2008","unstructured":"Kim, B. Thyroid hormone as a determinant of energy expenditure and the basal metabolic rate. Thyroid 18, 141\u2013144 (2008).","journal-title":"Thyroid"},{"key":"1190_CR40","doi-asserted-by":"publisher","first-page":"4659","DOI":"10.3390\/ijms25094659","volume":"25","author":"A G\u00f3mez-Hern\u00e1ndez","year":"2024","unstructured":"G\u00f3mez-Hern\u00e1ndez, A. et al. New mediators in the crosstalk between different adipose tissues. Int. J. Mol. Sci. 25, 4659 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"1190_CR41","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s12020-019-02025-5","volume":"66","author":"R Senese","year":"2019","unstructured":"Senese, R., Cioffi, F., Petito, G., Goglia, F. & Lanni, A. Thyroid hormone metabolites and analogues. Endocrine 66, 105\u2013114 (2019).","journal-title":"Endocrine"},{"key":"1190_CR42","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1080\/15548627.2018.1511263","volume":"15","author":"WW Yau","year":"2019","unstructured":"Yau, W. W. et al. Thyroid hormone (T3) stimulates brown adipose tissue activation via mitochondrial biogenesis and MTOR-mediated mitophagy. Autophagy 15, 131\u2013150 (2019).","journal-title":"Autophagy"},{"key":"1190_CR43","doi-asserted-by":"publisher","first-page":"997","DOI":"10.3390\/cells11060997","volume":"11","author":"F Cioffi","year":"2022","unstructured":"Cioffi, F., Giacco, A., Goglia, F. & Silvestri, E. Bioenergetic aspects of mitochondrial actions of thyroid hormones. Cells 11, 997 (2022).","journal-title":"Cells"},{"key":"1190_CR44","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/0026-0495(86)90142-3","volume":"35","author":"SL Welle","year":"1986","unstructured":"Welle, S. L. & Campbell, R. G. Decrease in resting metabolic rate during rapid weight loss is reversed by low dose thyroid hormone treatment. Metabolism 35, 289\u2013291 (1986).","journal-title":"Metabolism"},{"key":"1190_CR45","doi-asserted-by":"publisher","first-page":"1443051","DOI":"10.3389\/fendo.2024.1443051","volume":"15","author":"X Sui","year":"2024","unstructured":"Sui, X. et al. The influence of extended fasting on thyroid hormone: local and differentiated regulatory mechanisms. Front. Endocrinol. 15, 1443051 (2024).","journal-title":"Front. Endocrinol."},{"key":"1190_CR46","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1677\/JOE-08-0125","volume":"198","author":"RL Araujo","year":"2008","unstructured":"Araujo, R. L. et al. Low replacement doses of thyroxine during food restriction restores type 1 deiodinase activity in rats and promotes body protein loss. J. Endocrinol. 198, 119\u2013125 (2008).","journal-title":"J. Endocrinol."},{"key":"1190_CR47","doi-asserted-by":"publisher","first-page":"474","DOI":"10.3389\/fendo.2018.00474","volume":"9","author":"AG Cicatiello","year":"2018","unstructured":"Cicatiello, A. G., Di Girolamo, D. & Dentice, M. Metabolic effects of the intracellular regulation of thyroid hormone: old players, new concepts. Front. Endocrinol. 9, 474 (2018).","journal-title":"Front. Endocrinol."},{"key":"1190_CR48","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/nrendo.2017.132","volume":"14","author":"MJ Betz","year":"2018","unstructured":"Betz, M. J. & Enerb\u00e4ck, S. Targeting thermogenesis in brown fat and muscle to treat obesity and metabolic disease. Nat. Rev. Endocrinol. 14, 77\u201387 (2018). A review discussing the potential role of targeting brown adipose tissue and thermogenesis in order to treat obesity.","journal-title":"Nat. Rev. Endocrinol."},{"key":"1190_CR49","doi-asserted-by":"crossref","unstructured":"Spiegelman, B. et al. Hormones, Metabolism and the Benefits of Exercise (Springer, 2017).","DOI":"10.1007\/978-3-319-72790-5"},{"key":"1190_CR50","doi-asserted-by":"publisher","first-page":"666595","DOI":"10.3389\/fendo.2021.666595","volume":"12","author":"CI Maushart","year":"2021","unstructured":"Maushart, C. I. et al. Free thyroxine levels are associated with cold induced thermogenesis in healthy euthyroid individuals. Front. Endocrinol. 12, 666595 (2021).","journal-title":"Front. Endocrinol."},{"key":"1190_CR51","doi-asserted-by":"publisher","first-page":"3020","DOI":"10.3390\/ijms21083020","volume":"21","author":"WW Yau","year":"2020","unstructured":"Yau, W. W. & Yen, P. M. Thermogenesis in adipose tissue activated by thyroid hormone. Int. J. Mol. Sci. 21, 3020 (2020). A discussion of the ways in which thyroid hormone can act on both brown and white adipose tissue to induce thermogenesis.","journal-title":"Int. J. Mol. Sci."},{"key":"1190_CR52","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1007\/s12011-023-03854-2","volume":"202","author":"YAR Ruswandi","year":"2024","unstructured":"Ruswandi, Y. A. R. et al. Understanding the roles of selenium on thyroid hormone-induced thermogenesis in adipose tissue. Biol. Trace Elem. Res. 202, 2419\u20132441 (2024).","journal-title":"Biol. Trace Elem. Res."},{"key":"1190_CR53","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.2337\/db09-0530","volume":"58","author":"M Saito","year":"2009","unstructured":"Saito, M. et al. High incidence of metabolically active brown adipose tissue in healthy adult humans: effects of cold exposure and adiposity. Diabetes 58, 1526\u20131531 (2009).","journal-title":"Diabetes"},{"key":"1190_CR54","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1210\/er.2012-1081","volume":"34","author":"P Lee","year":"2013","unstructured":"Lee, P., Swarbrick, M. M. & Ho, K. K. Brown adipose tissue in adult humans: a metabolic renaissance. Endocr. Rev. 34, 413\u2013438 (2013).","journal-title":"Endocr. Rev."},{"key":"1190_CR55","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1007\/s40618-023-02125-0","volume":"46","author":"VA Genchi","year":"2023","unstructured":"Genchi, V. A. et al. Pharmacological modulation of adaptive thermogenesis: new clues for obesity management? J. Endocrinol. Invest. 46, 2213\u20132236 (2023).","journal-title":"J. Endocrinol. Invest."},{"key":"1190_CR56","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cmet.2024.11.002","volume":"37","author":"AM Cypess","year":"2025","unstructured":"Cypess, A. M. et al. Emerging debates and resolutions in brown adipose tissue research. Cell Metab. 37, 12\u201333 (2025).","journal-title":"Cell Metab."},{"key":"1190_CR57","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3389\/fphys.2014.00479","volume":"5","author":"MJ Obregon","year":"2014","unstructured":"Obregon, M. J. Adipose tissues and thyroid hormones. Front. Physiol. 5, 479 (2014).","journal-title":"Front. Physiol."},{"key":"1190_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14147","volume":"8","author":"L Shu","year":"2017","unstructured":"Shu, L. et al. A-FABP mediates adaptive thermogenesis by promoting intracellular activation of thyroid hormones in brown adipocytes. Nat. Commun. 8, 14147 (2017).","journal-title":"Nat. Commun."},{"key":"1190_CR59","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1172\/JCI200113803","volume":"108","author":"LA de Jesus","year":"2001","unstructured":"de Jesus, L. A. et al. The type 2 iodothyronine deiodinase is essential for adaptive thermogenesis in brown adipose tissue. J. Clin. Invest. 108, 1379\u20131385 (2001).","journal-title":"J. Clin. Invest."},{"key":"1190_CR60","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1210\/en.2009-0667","volume":"151","author":"MO Ribeiro","year":"2010","unstructured":"Ribeiro, M. O. et al. Expression of uncoupling protein 1 in mouse brown adipose tissue is thyroid hormone receptor-\u03b2 isoform specific and required for adaptive thermogenesis. Endocrinology 151, 432\u2013440 (2010).","journal-title":"Endocrinology"},{"key":"1190_CR61","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3389\/fendo.2018.00254","volume":"9","author":"F Cioffi","year":"2018","unstructured":"Cioffi, F., Gentile, A., Silvestri, E., Goglia, F. & Lombardi, A. Effect of iodothyronines on thermogenesis: focus on brown adipose tissue. Front. Endocrinol. 9, 254 (2018).","journal-title":"Front. Endocrinol."},{"key":"1190_CR62","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.3390\/cells10061327","volume":"10","author":"Y Zekri","year":"2021","unstructured":"Zekri, Y., Flamant, F. & Gauthier, K. Central vs. peripheral action of thyroid hormone in adaptive thermogenesis: a burning topic. Cells 10, 1327 (2021).","journal-title":"Cells"},{"key":"1190_CR63","doi-asserted-by":"publisher","first-page":"562","DOI":"10.2337\/db22-0656","volume":"72","author":"Y Ma","year":"2023","unstructured":"Ma, Y. et al. Adipocyte thyroid hormone \u03b2 receptor-mediated hormone action fine-tunes intracellular glucose and lipid metabolism and systemic homeostasis. Diabetes 72, 562\u2013574 (2023).","journal-title":"Diabetes"},{"key":"1190_CR64","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.mce.2017.01.018","volume":"458","author":"Z Zhang","year":"2017","unstructured":"Zhang, Z., Boelen, A., Bisschop, P. H., Kalsbeek, A. & Fliers, E. Hypothalamic effects of thyroid hormone. Mol. Cell Endocrinol. 458, 143\u2013148 (2017). A review of the data in animals addressing the effects of T3 administration into hypothalamic nuclei and the consequences for metabolism and feeding behaviour.","journal-title":"Mol. Cell Endocrinol."},{"key":"1190_CR65","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s12276-022-00741-z","volume":"54","author":"LT Tran","year":"2022","unstructured":"Tran, L. T. et al. Hypothalamic control of energy expenditure and thermogenesis. Exp. Mol. Med. 54, 358\u2013369 (2022).","journal-title":"Exp. Mol. Med."},{"key":"1190_CR66","doi-asserted-by":"publisher","first-page":"578830","DOI":"10.3389\/fendo.2020.578830","volume":"11","author":"H Liu","year":"2020","unstructured":"Liu, H., Xu, Y. & Hu, F. AMPK in the ventromedial nucleus of the hypothalamus: a key regulator for thermogenesis. Front. Endocrinol. 11, 578830 (2020).","journal-title":"Front. Endocrinol."},{"key":"1190_CR67","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1159\/000493976","volume":"7","author":"Z Zhang","year":"2018","unstructured":"Zhang, Z., Boelen, A., Kalsbeek, A. & Fliers, E. TRH neurons and thyroid hormone coordinate the hypothalamic response to cold. Eur. Thyroid. J. 7, 279\u2013288 (2018).","journal-title":"Eur. Thyroid. J."},{"key":"1190_CR68","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1159\/000492785","volume":"107","author":"Z Zhang","year":"2018","unstructured":"Zhang, Z. et al. Administration of thyrotropin-releasing hormone in the hypothalamic paraventricular nucleus of male rats mimics the metabolic cold defense response. Neuroendocrinology 107, 267\u2013279 (2018).","journal-title":"Neuroendocrinology"},{"key":"1190_CR69","doi-asserted-by":"publisher","first-page":"306510","DOI":"10.4061\/2011\/306510","volume":"2011","author":"A Amin","year":"2011","unstructured":"Amin, A., Dhillo, W. S. & Murphy, K. G. The central effects of thyroid hormones on appetite. J. Thyroid. Res. 2011, 306510 (2011).","journal-title":"J. Thyroid. Res."},{"key":"1190_CR70","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s12276-021-00597-9","volume":"53","author":"ES Yoo","year":"2021","unstructured":"Yoo, E. S., Yu, J. & Sohn, J. W. Neuroendocrine control of appetite and metabolism. Exp. Mol. Med. 53, 505\u2013516 (2021).","journal-title":"Exp. Mol. Med."},{"key":"1190_CR71","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2322692121","volume":"121","author":"D Rojo","year":"2024","unstructured":"Rojo, D. et al. A mammalian tripartite enhancer cluster controls hypothalamic Pomc expression, food intake, and body weight. Proc. Natl Acad. Sci. USA 121, e2322692121 (2024).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1190_CR72","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/nn.4202","volume":"19","author":"MJ Krashes","year":"2016","unstructured":"Krashes, M. J., Lowell, B. B. & Garfield, A. S. Melanocortin-4 receptor-regulated energy homeostasis. Nat. Neurosci. 19, 206\u2013219 (2016).","journal-title":"Nat. Neurosci."},{"key":"1190_CR73","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1016\/j.celrep.2017.05.066","volume":"19","author":"S Hameed","year":"2017","unstructured":"Hameed, S. et al. Thyroid hormone receptor beta in the ventromedial hypothalamus is essential for the physiological regulation of food intake and body weight. Cell Rep. 19, 2202\u20132209 (2017).","journal-title":"Cell Rep."},{"key":"1190_CR74","doi-asserted-by":"publisher","first-page":"5252","DOI":"10.1210\/en.2004-0545","volume":"145","author":"WM Kong","year":"2004","unstructured":"Kong, W. M. et al. Triiodothyronine stimulates food intake via the hypothalamic ventromedial nucleus independent of changes in energy expenditure. Endocrinology 145, 5252\u20135258 (2004).","journal-title":"Endocrinology"},{"key":"1190_CR75","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cmet.2006.12.002","volume":"5","author":"A Coppola","year":"2007","unstructured":"Coppola, A. et al. A central thermogenic-like mechanism in feeding regulation: an interplay between arcuate nucleus T3 and UCP2. Cell Metab. 5, 21\u201333 (2007).","journal-title":"Cell Metab."},{"key":"1190_CR76","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/path.3984","volume":"227","author":"L Varela","year":"2012","unstructured":"Varela, L. et al. Hypothalamic mTOR pathway mediates thyroid hormone-induced hyperphagia in hyperthyroidism. J. Pathol. 227, 209\u2013222 (2012).","journal-title":"J. Pathol."},{"key":"1190_CR77","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S2213-8587(24)00316-4","volume":"13","author":"F Rubino","year":"2025","unstructured":"Rubino, F. et al. Definition and diagnostic criteria of clinical obesity. Lancet Diabetes Endocrinol. 13, 221\u2013262 (2025).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"1190_CR78","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1007\/s00415-020-10394-5","volume":"268","author":"B Jordan","year":"2021","unstructured":"Jordan, B., Uer, O., Buchholz, T., Spens, A. & Zierz, S. Physical fatigability and muscle pain in patients with Hashimoto thyroiditis. J. Neurol. 268, 2441\u20132449 (2021).","journal-title":"J. Neurol."},{"key":"1190_CR79","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1007\/s40618-017-0661-7","volume":"40","author":"D Gallo","year":"2017","unstructured":"Gallo, D. et al. Physical performance in newly diagnosed hypothyroidism: a pilot study. J. Endocrinol. Invest. 40, 1099\u20131106 (2017).","journal-title":"J. Endocrinol. Invest."},{"key":"1190_CR80","doi-asserted-by":"publisher","first-page":"211","DOI":"10.4161\/derm.17027","volume":"3","author":"JD Safer","year":"2011","unstructured":"Safer, J. D. Thyroid hormone action on skin. Dermatoendocrinol 3, 211\u2013215 (2011).","journal-title":"Dermatoendocrinol"},{"key":"1190_CR81","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1210\/jcem-17-8-925","volume":"17","author":"JL Gabrilove","year":"1957","unstructured":"Gabrilove, J. L. & Ludwig, A. W. The histogenesis of myxedema. J. Clin. Endocrinol. Metab. 17, 925\u2013932 (1957).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1190_CR82","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3390\/nu16010087","volume":"16","author":"B Biondi","year":"2023","unstructured":"Biondi, B. Subclinical hypothyroidism in patients with obesity and metabolic syndrome: a narrative review. Nutrients 16, 87 (2023). The link between metabolic syndrome and subclinical hypothyroidism is explored in this review, including discussion of the role of thyroid hormone treatment.","journal-title":"Nutrients"},{"key":"1190_CR83","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1111\/j.1365-2265.2011.04009.x","volume":"74","author":"A Svare","year":"2011","unstructured":"Svare, A., Nilsen, T. I., Bjoro, T., Asvold, B. O. & Langhammer, A. Serum TSH related to measures of body mass: longitudinal data from the HUNT study, Norway. Clin. Endocrinol. 74, 769\u2013775 (2011).","journal-title":"Clin. Endocrinol."},{"key":"1190_CR84","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1001\/archinte.168.6.587","volume":"168","author":"CS Fox","year":"2008","unstructured":"Fox, C. S. et al. Relations of thyroid function to body weight: cross-sectional and longitudinal observations in a community-based sample. Arch. Intern. Med. 168, 587\u2013592 (2008).","journal-title":"Arch. Intern. Med."},{"key":"1190_CR85","doi-asserted-by":"publisher","first-page":"5023","DOI":"10.1210\/jc.2009-1180","volume":"94","author":"BO Asvold","year":"2009","unstructured":"Asvold, B. O., Bjoro, T. & Vatten, L. J. Association of serum TSH with high body mass differs between smokers and never-smokers. J. Clin. Endocrinol. Metab. 94, 5023\u20135027 (2009).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1190_CR86","first-page":"771","volume":"82","author":"H Zulewski","year":"1997","unstructured":"Zulewski, H., Muller, B., Exer, P., Miserez, A. R. & Staub, J. J. Estimation of tissue hypothyroidism by a new clinical score: evaluation of patients with various grades of hypothyroidism and controls. J. Clin. Endocrinol. Metab. 82, 771\u2013776 (1997). A classic cross-sectional study of a clinical score and its performance in indicating degrees of biochemical hypothyroidism.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1190_CR87","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.3389\/fimmu.2019.02349","volume":"10","author":"RH Song","year":"2019","unstructured":"Song, R. H. et al. The impact of obesity on thyroid autoimmunity and dysfunction: a systematic review and meta-analysis. Front. Immunol. 10, 2349 (2019).","journal-title":"Front. Immunol."},{"key":"1190_CR88","doi-asserted-by":"publisher","first-page":"1379124","DOI":"10.3389\/fmolb.2024.1379124","volume":"11","author":"M Jing","year":"2024","unstructured":"Jing, M. et al. Exploring the link between obesity and hypothyroidism in autoimmune thyroid diseases: a metabolic perspective. Front. Mol. Biosci. 11, 1379124 (2024).","journal-title":"Front. Mol. Biosci."},{"key":"1190_CR89","doi-asserted-by":"publisher","first-page":"4215848","DOI":"10.1155\/2018\/4215848","volume":"2018","author":"M Zhao","year":"2018","unstructured":"Zhao, M. et al. Palmitic acid downregulates thyroglobulin (Tg), sodium iodide symporter (NIS), and thyroperoxidase (TPO) in human primary thyrocytes: a potential mechanism by which lipotoxicity affects thyroid? Int. J. Endocrinol. 2018, 4215848 (2018).","journal-title":"Int. J. Endocrinol."},{"key":"1190_CR90","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s13139-014-0308-y","volume":"49","author":"S Choi","year":"2015","unstructured":"Choi, S. et al. Comparison of therapeutic efficacy and clinical parameters between recombinant human thyroid stimulating hormone and thyroid hormone withdrawal in high-dose radioiodine treatment with differentiated thyroid cancer. Nucl. Med. Mol. Imaging 49, 115\u2013121 (2015).","journal-title":"Nucl. Med. Mol. Imaging"},{"key":"1190_CR91","doi-asserted-by":"publisher","first-page":"834674","DOI":"10.3389\/fendo.2022.834674","volume":"13","author":"B Lin","year":"2022","unstructured":"Lin, B. et al. Randomized clinical trial: probiotics alleviated oral\u2013gut microbiota dysbiosis and thyroid hormone withdrawal-related complications in thyroid cancer patients before radioiodine therapy following thyroidectomy. Front. Endocrinol. 13, 834674 (2022).","journal-title":"Front. Endocrinol."},{"key":"1190_CR92","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3803\/EnM.2015.30.3.343","volume":"30","author":"SY Sohn","year":"2015","unstructured":"Sohn, S. Y. et al. Weight changes in patients with differentiated thyroid carcinoma during postoperative long-term follow-up under thyroid stimulating hormone suppression. Endocrinol. Metab. 30, 343\u2013351 (2015).","journal-title":"Endocrinol. Metab."},{"key":"1190_CR93","first-page":"859","volume":"3","author":"L Portmann","year":"2007","unstructured":"Portmann, L. & Giusti, V. Obesity and hypothyroidism: myth or reality? [French]. Rev. Med. Suisse 3, 859\u2013862 (2007).","journal-title":"Rev. Med. Suisse"},{"key":"1190_CR94","doi-asserted-by":"publisher","first-page":"E99","DOI":"10.1210\/jc.2010-1521","volume":"96","author":"J Karmisholt","year":"2011","unstructured":"Karmisholt, J., Andersen, S. & Laurberg, P. Weight loss after therapy of hypothyroidism is mainly caused by excretion of excess body water associated with myxoedema. J. Clin. Endocrinol. Metab. 96, E99\u2013E103 (2011). A seminal prospective study showing that weight loss with treatment of hypothyroidism is largely due to loss of body water rather than fat mass.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1190_CR95","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2147\/IJGM.S206983","volume":"12","author":"M Rios-Prego","year":"2019","unstructured":"Rios-Prego, M., Anibarro, L. & Sanchez-Sobrino, P. Relationship between thyroid dysfunction and body weight: a not so evident paradigm. Int. J. Gen. Med. 12, 299\u2013304 (2019).","journal-title":"Int. J. Gen. Med."},{"key":"1190_CR96","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1001\/archinte.165.15.1714","volume":"165","author":"A Roos","year":"2005","unstructured":"Roos, A., Linn-Rasker, S. P., van Domburg, R. T., Tijssen, J. P. & Berghout, A. The starting dose of levothyroxine in primary hypothyroidism treatment: a prospective, randomized, double-blind trial. Arch. Intern. Med. 165, 1714\u20131720 (2005).","journal-title":"Arch. Intern. Med."},{"key":"1190_CR97","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1089\/thy.2018.0436","volume":"29","author":"CI Maushart","year":"2019","unstructured":"Maushart, C. I., Loeliger, R., Gashi, G., Christ-Crain, M. & Betz, M. J. Resolution of hypothyroidism restores cold-induced thermogenesis in humans. Thyroid 29, 493\u2013501 (2019).","journal-title":"Thyroid"},{"key":"1190_CR98","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1177\/003693309003500609","volume":"35","author":"J Pears","year":"1990","unstructured":"Pears, J., Jung, R. T. & Gunn, A. Long-term weight changes in treated hyperthyroid and hypothyroid patients. Scott. Med. J. 35, 180\u2013182 (1990).","journal-title":"Scott. Med. J."},{"key":"1190_CR99","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/S0002-9343(02)01022-7","volume":"112","author":"WM Kong","year":"2002","unstructured":"Kong, W. M. et al. A 6-month randomized trial of thyroxine treatment in women with mild subclinical hypothyroidism. Am. J. Med. 112, 348\u2013354 (2002).","journal-title":"Am. J. Med."},{"key":"1190_CR100","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1080\/02640414.2021.1940696","volume":"39","author":"JAC Lankhaar","year":"2021","unstructured":"Lankhaar, J. A. C. et al. Physical activity, sports participation and exercise-related constraints in adult women with primary hypothyroidism treated with thyroid hormone replacement therapy. J. Sports Sci. 39, 2493\u20132502 (2021).","journal-title":"J. Sports Sci."},{"key":"1190_CR101","doi-asserted-by":"publisher","first-page":"20220224","DOI":"10.1098\/rstb.2022.0224","volume":"378","author":"JCK Wells","year":"2023","unstructured":"Wells, J. C. K. Natural selection and human adiposity: crafty genotype, thrifty phenotype. Philos. Trans. R. Soc. Lond. B Biol. Sci. 378, 20220224 (2023).","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"1190_CR102","doi-asserted-by":"publisher","first-page":"jeb167254","DOI":"10.1242\/jeb.167254","volume":"221","author":"JR Speakman","year":"2018","unstructured":"Speakman, J. R. The evolution of body fatness: trading off disease and predation risk. J. Exp. Biol. 221, jeb167254 (2018).","journal-title":"J. Exp. Biol."},{"key":"1190_CR103","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s12020-020-02334-0","volume":"71","author":"A Kozacz","year":"2021","unstructured":"Kozacz, A., Assis, G. G., Sanocka, U. & Ziemba, A. W. Standard hypothyroid treatment did not restore proper metabolic response to carbohydrate. Endocrine 71, 96\u2013103 (2021). In this study, levothyroxine treatment for hypothyroidism did not restore the normal metabolic reaction to carbohydrate observed in control individuals.","journal-title":"Endocrine"},{"key":"1190_CR104","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1089\/thy.2015.0345","volume":"26","author":"MH Samuels","year":"2016","unstructured":"Samuels, M. H. et al. Effects of levothyroxine replacement or suppressive therapy on energy expenditure and body composition. Thyroid 26, 347\u2013355 (2016).","journal-title":"Thyroid"},{"key":"1190_CR105","doi-asserted-by":"publisher","first-page":"4163","DOI":"10.1210\/jc.2018-01203","volume":"103","author":"MH Samuels","year":"2018","unstructured":"Samuels, M. H., Kolobova, I., Niederhausen, M., Purnell, J. Q. & Schuff, K. G. Effects of altering levothyroxine dose on energy expenditure and body composition in subjects treated with LT4. J. Clin. Endocrinol. Metab. 103, 4163\u20134175 (2018). In patients being treated with levothyroxine for hypothyroidism, altering their doses to vary thyroid-stimulating hormone levels did not have major effects on energy expenditure or body composition.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1190_CR106","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1089\/thy.2020.0720","volume":"31","author":"J Jonklaas","year":"2021","unstructured":"Jonklaas, J. et al. Evidence-based use of levothyroxine\/liothyronine combinations in treating hypothyroidism: a consensus document. Thyroid 31, 156\u2013182 (2021).","journal-title":"Thyroid"},{"key":"1190_CR107","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1210\/jc.2004-2111","volume":"90","author":"BC Appelhof","year":"2005","unstructured":"Appelhof, B. C. et al. Combined therapy with levothyroxine and liothyronine in two ratios, compared with levothyroxine monotherapy in primary hypothyroidism: a double-blind, randomized, controlled clinical trial. J. Clin. Endocrinol. Metab. 90, 2666\u20132674 (2005).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1190_CR108","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1210\/jc.2012-4107","volume":"98","author":"TD Hoang","year":"2013","unstructured":"Hoang, T. D., Olsen, C. H., Mai, V. Q., Clyde, P. W. & Shakir, M. K. Desiccated thyroid extract compared with levothyroxine in the treatment of hypothyroidism: a randomized, double-blind, crossover study. J. Clin. Endocrinol. Metab. 98, 1982\u20131990 (2013).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1190_CR109","doi-asserted-by":"publisher","first-page":"e4400","DOI":"10.1210\/clinem\/dgab478","volume":"106","author":"MKM Shakir","year":"2021","unstructured":"Shakir, M. K. M. et al. Comparative effectiveness of levothyroxine, desiccated thyroid extract, and levothyroxine\u2009+\u2009Liothyronine in hypothyroidism. J. Clin. Endocrinol. Metab. 106, e4400\u2013e4413 (2021).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1190_CR110","doi-asserted-by":"publisher","first-page":"1522753","DOI":"10.3389\/fendo.2025.1522753","volume":"16","author":"GQ Phan","year":"2025","unstructured":"Phan, G. Q. et al. A feasibility double-blind trial of levothyroxine vs. levothyroxine-liothyronine in postsurgical hypothyroidism. Front. Endocrinol. 16, 1522753 (2025).","journal-title":"Front. Endocrinol."},{"key":"1190_CR111","doi-asserted-by":"publisher","first-page":"3466","DOI":"10.1210\/jc.2011-1329","volume":"96","author":"FS Celi","year":"2011","unstructured":"Celi, F. S. et al. Metabolic effects of liothyronine therapy in hypothyroidism: a randomized, double-blind, crossover trial of liothyronine versus levothyroxine. J. Clin. Endocrinol. Metab. 96, 3466\u20133474 (2011).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1190_CR112","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1111\/j.1365-2265.2009.03700.x","volume":"72","author":"FS Celi","year":"2010","unstructured":"Celi, F. S. et al. The pharmacodynamic equivalence of levothyroxine and liothyronine: a randomized, double blind, cross-over study in thyroidectomized patients. Clin. Endocrinol. 72, 709\u2013715 (2010).","journal-title":"Clin. Endocrinol."},{"key":"1190_CR113","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/S2213-8587(23)00005-0","volume":"11","author":"WM Wiersinga","year":"2023","unstructured":"Wiersinga, W. M., Poppe, K. G. & Effraimidis, G. Hyperthyroidism: aetiology, pathogenesis, diagnosis, management, complications, and prognosis. Lancet Diabetes Endocrinol. 11, 282\u2013298 (2023).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"1190_CR114","volume":"16","author":"ML Guia Lopes","year":"2024","unstructured":"Guia Lopes, M. L. et al. Exploring post-treatment weight changes in overweight and obese patients with Graves\u2019 disease: a retrospective analysis. Cureus 16, e59408 (2024).","journal-title":"Cureus"},{"key":"1190_CR115","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1159\/000512078","volume":"10","author":"J Karmisholt","year":"2021","unstructured":"Karmisholt, J., Carl\u00e9, A. & Andersen, S. Body weight changes in hyperthyroidism: timing and possible explanations during a one year repeated measurement study. Eur. Thyroid. J. 10, 208\u2013214 (2021).","journal-title":"Eur. Thyroid. J."},{"key":"1190_CR116","doi-asserted-by":"publisher","first-page":"715370","DOI":"10.1155\/2011\/715370","volume":"2011","author":"LP Klieverik","year":"2011","unstructured":"Klieverik, L. P. et al. Energy homeostasis and body weight before and after cessation of block and replacement therapy in euthyroid patients with Graves\u2019 disease. Int. J. Endocrinol. 2011, 715370 (2011).","journal-title":"Int. J. Endocrinol."},{"key":"1190_CR117","first-page":"4269","volume":"83","author":"L Lonn","year":"1998","unstructured":"Lonn, L. et al. Body weight and body composition changes after treatment of hyperthyroidism. J. Clin. Endocrinol. Metab. 83, 4269\u20134273 (1998).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1190_CR118","first-page":"115","volume":"150","author":"P Cugini","year":"1999","unstructured":"Cugini, P. et al. Hunger sensation in Graves\u2019 disease before and after pharmacological therapy. Clin. Ter. 150, 115\u2013119 (1999).","journal-title":"Clin. Ter."},{"key":"1190_CR119","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1385\/ENDO:27:1:055","volume":"27","author":"S Rojdmark","year":"2005","unstructured":"Rojdmark, S., Calissendorff, J., Danielsson, O. & Brismar, K. Hunger-satiety signals in patients with Graves\u2019 thyrotoxicosis before, during, and after long-term pharmacological treatment. Endocrine 27, 55\u201361 (2005).","journal-title":"Endocrine"},{"key":"1190_CR120","doi-asserted-by":"publisher","DOI":"10.1111\/cob.12328","volume":"9","author":"A Kyriacou","year":"2019","unstructured":"Kyriacou, A., Kyriacou, A., Makris, K. C., Syed, A. A. & Perros, P. Weight gain following treatment of hyperthyroidism \u2014 a forgotten tale. Clin. Obes. 9, e12328 (2019).","journal-title":"Clin. Obes."},{"key":"1190_CR121","doi-asserted-by":"publisher","first-page":"5848","DOI":"10.1210\/jcem.86.12.8112","volume":"86","author":"H Pijl","year":"2001","unstructured":"Pijl, H. et al. Food choice in hyperthyroidism: potential influence of the autonomic nervous system and brain serotonin precursor availability. J. Clin. Endocrinol. Metab. 86, 5848\u20135853 (2001).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1190_CR122","first-page":"529","volume":"93","author":"J Brunova","year":"2003","unstructured":"Brunova, J., Bruna, J., Joubert, G. & Koning, M. Weight gain in patients after therapy for hyperthyroidism. S. Afr. Med. J. 93, 529\u2013531 (2003).","journal-title":"S. Afr. Med. J."},{"key":"1190_CR123","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1046\/j.1365-2265.2001.01329.x","volume":"55","author":"J Dale","year":"2001","unstructured":"Dale, J., Daykin, J., Holder, R., Sheppard, M. C. & Franklyn, J. A. Weight gain following treatment of hyperthyroidism. Clin. Endocrinol. 55, 233\u2013239 (2001).","journal-title":"Clin. Endocrinol."},{"key":"1190_CR124","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1089\/thy.2018.0731","volume":"29","author":"B Torlinska","year":"2019","unstructured":"Torlinska, B., Nichols, L., Mohammed, M. A., McCabe, C. & Boelaert, K. Patients treated for hyperthyroidism are at increased risk of becoming obese: findings from a large prospective secondary care cohort. Thyroid 29, 1380\u20131389 (2019). In this prospective study, treatment with radioactive iodine for hyperthyroidism was associated with greater weight gain than treatment with antithyroidal medications.","journal-title":"Thyroid"},{"key":"1190_CR125","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13633-017-0044-z","volume":"2017","author":"M Chen","year":"2017","unstructured":"Chen, M., Lash, M., Nebesio, T. & Eugster, E. Change in BMI after radioactive iodine ablation for Graves disease. Int. J. Pediatr. Endocrinol. 2017, 5 (2017).","journal-title":"Int. J. Pediatr. Endocrinol."},{"key":"1190_CR126","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1159\/000512734","volume":"10","author":"L Russo","year":"2021","unstructured":"Russo, L. et al. Metabolic changes after radioiodine correction of grade 1 and grade 2 subclinical hyperthyroidism. Eur. Thyroid. J. 10, 382\u2013389 (2021).","journal-title":"Eur. Thyroid. J."},{"key":"1190_CR127","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1089\/thy.2000.10.1107","volume":"10","author":"S Tigas","year":"2000","unstructured":"Tigas, S., Idiculla, J., Beckett, G. & Toft, A. Is excessive weight gain after ablative treatment of hyperthyroidism due to inadequate thyroid hormone therapy? Thyroid 10, 1107\u20131111 (2000).","journal-title":"Thyroid"},{"key":"1190_CR128","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1089\/thy.1997.7.401","volume":"7","author":"RE de la Rosa","year":"1997","unstructured":"de la Rosa, R. E., Hennessey, J. V. & Tucci, J. R. A longitudinal study of changes in body mass index and total body composition after radioiodine treatment for thyrotoxicosis. Thyroid 7, 401\u2013405 (1997).","journal-title":"Thyroid"},{"key":"1190_CR129","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.2147\/DMSO.S458486","volume":"17","author":"M Li","year":"2024","unstructured":"Li, M. et al. Visceral fat area and subcutaneous fat area increase in hyperthyroidism patients after treatment \u2014 a single-group repeated-measures trial. Diabetes Metab. Syndr. Obes. 17, 2165\u20132176 (2024).","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"1190_CR130","first-page":"808","volume":"66","author":"A Patil","year":"2022","unstructured":"Patil, A. et al. Mediators of energy homeostasis in hyperthyroidism. Arch. Endocrinol. Metab. 66, 808\u2013814 (2022).","journal-title":"Arch. Endocrinol. Metab."},{"key":"1190_CR131","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1210\/jc.2002-021302","volume":"88","author":"AL Riis","year":"2003","unstructured":"Riis, A. L., Hansen, T. K., Moller, N., Weeke, J. & Jorgensen, J. O. Hyperthyroidism is associated with suppressed circulating ghrelin levels. J. Clin. Endocrinol. Metab. 88, 853\u2013857 (2003).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1190_CR132","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1089\/thy.2015.0602","volume":"26","author":"CL Chng","year":"2016","unstructured":"Chng, C. L. et al. Physiological and metabolic changes during the transition from hyperthyroidism to euthyroidism in Graves\u2019 disease. Thyroid 26, 1422\u20131430 (2016). There was a significant increase in body weight and fat mass in this study following restoration of euthyroidism in individuals with hyperthyroidism.","journal-title":"Thyroid"},{"key":"1190_CR133","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.2169\/internalmedicine.4462-20","volume":"59","author":"A Hayashi","year":"2020","unstructured":"Hayashi, A. et al. Short-term change in resting energy expenditure and body compositions in therapeutic process for Graves\u2019 disease. Intern. Med. 59, 1827\u20131833 (2020). In this study, body weight increased after treatment of Graves disease, while resting energy expenditure significantly decreased.","journal-title":"Intern. Med."},{"key":"1190_CR134","volume":"16","author":"T Fukuda","year":"2024","unstructured":"Fukuda, T. et al. Alterations in body weight and composition in patients with Graves\u2019 disease treated with total thyroidectomy. Cureus 16, e63338 (2024).","journal-title":"Cureus"},{"key":"1190_CR135","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1210\/clinem\/dgab706","volume":"107","author":"CI Maushart","year":"2022","unstructured":"Maushart, C. I. et al. Resting energy expenditure and cold-induced thermogenesis in patients with overt hyperthyroidism. J. Clin. Endocrinol. Metab. 107, 450\u2013461 (2022).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1190_CR136","doi-asserted-by":"publisher","first-page":"3663","DOI":"10.1210\/jc.2009-0899","volume":"94","author":"EM Kaptein","year":"2009","unstructured":"Kaptein, E. M., Beale, E. & Chan, L. S. Thyroid hormone therapy for obesity and nonthyroidal illnesses: a systematic review. J. Clin. Endocrinol. Metab. 94, 3663\u20133675 (2009).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1190_CR137","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s40618-024-02409-z","volume":"48","author":"JC Galofr\u00e9","year":"2024","unstructured":"Galofr\u00e9, J. C. et al. Treatment of obesity with thyroid hormones in Europe. Data from the THESIS* collaboration. J. Endocrinol. Invest. 48, 201\u2013212 (2024). Of physicians responding to a survey, 5% stated that thyroid hormone might be indicated as a treatment for obesity in euthyroid patients resistant to lifestyle interventions.","journal-title":"J. Endocrinol. Invest."},{"key":"1190_CR138","doi-asserted-by":"publisher","first-page":"340","DOI":"10.4158\/PS-2019-0540","volume":"26","author":"MS Irwig","year":"2020","unstructured":"Irwig, M. S. et al. Off-label use and misuse of testosterone, growth hormone, thyroid hormone, and adrenal supplements: risks and costs of a growing problem. Endocr. Pract. 26, 340\u2013353 (2020).","journal-title":"Endocr. Pract."},{"key":"1190_CR139","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1089\/thy.2020.0071","volume":"30","author":"R Zucchi","year":"2020","unstructured":"Zucchi, R. Thyroid hormone analogues: an update. Thyroid 30, 1099\u20131105 (2020).","journal-title":"Thyroid"},{"key":"1190_CR140","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3389\/fmed.2020.00331","volume":"7","author":"F Saponaro","year":"2020","unstructured":"Saponaro, F., Sestito, S., Runfola, M., Rapposelli, S. & Chiellini, G. Selective thyroid hormone receptor-beta (TR\u03b2) agonists: new perspectives for the treatment of metabolic and neurodegenerative disorders. Front. Med. 7, 331 (2020).","journal-title":"Front. Med."},{"key":"1190_CR141","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1210\/jc.2009-1209","volume":"95","author":"PW Ladenson","year":"2010","unstructured":"Ladenson, P. W. et al. Effects of the thyromimetic agent diiodothyropropionic acid on body weight, body mass index, and serum lipoproteins: a pilot prospective, randomized, controlled study. J. Clin. Endocrinol. Metab. 95, 1349\u20131354 (2010).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1190_CR142","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1161\/CIRCULATIONAHA.108.834424","volume":"119","author":"S Goldman","year":"2009","unstructured":"Goldman, S. et al. DITPA (3,5-diiodothyropropionic acid), a thyroid hormone analog to treat heart failure: phase II trial Veterans Affairs Cooperative Study. Circulation 119, 3093\u20133100 (2009).","journal-title":"Circulation"},{"key":"1190_CR143","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1056\/NEJMoa0905633","volume":"362","author":"PW Ladenson","year":"2010","unstructured":"Ladenson, P. W. et al. Use of the thyroid hormone analogue eprotirome in statin-treated dyslipidemia. N. Engl. J. Med. 362, 906\u2013916 (2010).","journal-title":"N. Engl. J. Med."},{"key":"1190_CR144","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S2213-8587(14)70006-3","volume":"2","author":"B Sjouke","year":"2014","unstructured":"Sjouke, B. et al. Eprotirome in patients with familial hypercholesterolaemia (the AKKA trial): a randomised, double-blind, placebo-controlled phase 3 study. Lancet Diabetes Endocrinol. 2, 455\u2013463 (2014).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"1190_CR145","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1159\/000539371","volume":"17","author":"European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO)","year":"2024","unstructured":"European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO) EASL-EASD-EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). Obes. Facts 17, 374\u2013444 (2024).","journal-title":"Obes. Facts"},{"key":"1190_CR146","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1152\/physrev.00030.2013","volume":"94","author":"R Mullur","year":"2014","unstructured":"Mullur, R., Liu, Y. Y. & Brent, G. A. Thyroid hormone regulation of metabolism. Physiol. Rev. 94, 355\u2013382 (2014).","journal-title":"Physiol. Rev."},{"key":"1190_CR147","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa2309000","volume":"390","author":"SA Harrison","year":"2024","unstructured":"Harrison, S. A. et al. A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis. N. Engl. J. Med. 390, 497\u2013509 (2024).","journal-title":"N. Engl. J. Med."},{"key":"1190_CR148","doi-asserted-by":"publisher","first-page":"3448","DOI":"10.3390\/ijms26073448","volume":"26","author":"M Boulos","year":"2025","unstructured":"Boulos, M. et al. Hidden in the fat: unpacking the metabolic tango between metabolic dysfunction-associated steatotic liver disease and metabolic syndrome. Int. J. Mol. Sci. 26, 3448 (2025).","journal-title":"Int. J. Mol. Sci."},{"key":"1190_CR149","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/liv.15723","volume":"44","author":"N Saatmann","year":"2024","unstructured":"Saatmann, N. et al. Association of thyroid function with non-alcoholic fatty liver disease in recent-onset diabetes. Liver Int. 44, 27\u201338 (2024).","journal-title":"Liver Int."},{"key":"1190_CR150","doi-asserted-by":"publisher","first-page":"155937","DOI":"10.1016\/j.metabol.2024.155937","volume":"157","author":"M Huttasch","year":"2024","unstructured":"Huttasch, M., Roden, M. & Kahl, S. Obesity and MASLD: is weight loss the (only) key to treat metabolic liver disease? Metabolism 157, 155937 (2024).","journal-title":"Metabolism"},{"key":"1190_CR151","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s11892-025-01579-1","volume":"25","author":"MW Takawy","year":"2025","unstructured":"Takawy, M. W. & Abdelmalek, M. F. Impact of weight loss on metabolic dysfunction associated steatohepatitis and hepatic fibrosis. Curr. Diab Rep. 25, 23 (2025).","journal-title":"Curr. Diab Rep."},{"key":"1190_CR152","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1089\/thy.2012.0153","volume":"22","author":"L Duntas","year":"2012","unstructured":"Duntas, L. et al. Thyroid disorders, noncommunicable diseases that gravely impact public health: a commentary and statement by the Advisory Board of the World Thyroid Federation. Thyroid 22, 566\u2013567 (2012).","journal-title":"Thyroid"}],"container-title":["Nature Reviews Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41574-025-01190-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41574-025-01190-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41574-025-01190-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T07:04:05Z","timestamp":1782284645000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41574-025-01190-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,14]]},"references-count":152,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["1190"],"URL":"https:\/\/doi.org\/10.1038\/s41574-025-01190-0","relation":{},"ISSN":["1759-5029","1759-5037"],"issn-type":[{"value":"1759-5029","type":"print"},{"value":"1759-5037","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,14]]},"assertion":[{"value":"19 September 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author declares no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}